Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Human Combinatorial Antibody Library-based Monoclonal Antibody VAY736

Known as: HuCAL-based Antibody VAY736, VAY736 
A fully human combinatorial antibody library (HuCAL)-derived monoclonal antibody targeting the B-cell-activating factor receptor (BAFF-R), with… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Objectives To evaluate the efficacy and safety of ianalumab (VAY736), a B cell-depleting, B cell activating factor receptor… Expand
Is this relevant?
2019
2019
Blocking BAFF-R early in ALL promotes killing of leukemic cells. However, if given at later disease stages, efficacy is limited… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2018
2018
Background According to international consensus, disease activity in primary Sjögren’s syndrome (pSS) patients shall be scored… Expand
Is this relevant?
2017
2017
Background Overexpression of B cell activating factor (BAFF) contributes to the pathogenesis of primary Sjögren's syndrome (pSS… Expand
Is this relevant?
2017
2017
Background Overexpression of B cell activating factor (BAFF) in salivary glands contributes to the pathogenesis of primary Sj… Expand
Is this relevant?
2016
2016
Background VAY736 is a novel, defucosylated, human IgG1 mAb targeting the receptor for B cell activating Factor of the TNF family… Expand
Is this relevant?